Background Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor,
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID-…

Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an
inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this …

Introduction COVID-19 disproportionately affects those with comorbidities and the elderly.
Hypertension is the most common pre-existing condition amongst COVID-19 patients. …

PURPOSE Genomic testing is recognized in national guidelines as essential to guide appropriate
therapy selection in metastatic colorectal cancer. Previous studies report adherence to …

e19531 Background: There is uncertainty about the prognostic and predictive significance
of t(11;14), long considered a standard risk cytogenetic abnormality in multiple myeloma (MM)…

e15123 Background: Molecular genotyping is essential to optimal treatment selection in
metastatic colon cancer (mCC) as mutations in exons 2,3,4 of KRAS and NRAS (expanded RAS…

e19528 Background: Record retrieval on behalf of a consenting patient within the context of
real-world data is not well understood. As the need for real-world data continues to expand, …

e19008 Background: Based upon interesting recent published findings, we characterize
disparities in clinical characteristics, treatment patterns, and outcomes for African American (AA) …

Methods: Within Hackensack Meridian Health network, the largest healthcare provider in
New Jersey, we performed a retrospective, multicenter, convenience sampling study of …

BackgroundHydroxychloroquine has been touted as a COVID-19 treatment. Tocilizumab,
an inhibitor of IL-6, has been proposed as a treatment of critically ill patients. ObjectiveTo …